Bundibugyo vaccine gap critical; clinical trials require 6-9 months minimum

Approved Ervebo vaccine targets Zaire strain only, proving useless against Bundibugyo variant. Two candidate vaccines exist but clinical entry requires 6-9 months minimum. 25-40% case fatality rate leaves only containment and supportive care.